Company
Aclaris Therapeutics
EMPOWERING PATIENTS THROUGH THERAPEUTIC INNOVATION
Also known as Aclaris Therapeutics Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Aclaris Therapeutics Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Welcome to Aclaris, a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions.
Funding snapshot
- Total raised
- $193MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $80M2024-11-19
Funding rounds
- Round, 2024
- $80M2024-11-19, SEC form D sold, 19 investors
- Round, 2020
- $11M2020-03-30, SEC form D sold, 1 investor
- Round, 2017
- $10M2017-08-03, SEC form D sold, 42 investors
- Round, 2016
- $20M2016-06-02, SEC form D sold, 9 investors
- Round, 2015
- $40M2015-08-28, SEC form D sold, 28 investors
- Round, 2014
- $10.6M2014-09-30, SEC form D sold, 25 investors
- Round, 2012
- $20.9M2012-08-30, SEC form D sold, 31 investors
Loading relationship preview